Abstract
Editorial introduction
The authors of the following paper make a significant contribution to establishing the efficacy of weekly iron supplementation to reach an important neglected anemic group, children 6 
Introduction
Iron-deficiency anemia during infancy and childhood remains one of the most important nutritional problems faced by developing countries. It is estimated that one in two children under five years of age in these countries is anemic (hemoglobin concentration below 110 g/L) [1] . A low dietary intake of available iron and high iron requirements associated with growth, often aggravated by parasitic infestations, are the main causes underlying the high prevalence of child anemia in developing countries [2] . The consequences of irondeficiency anemia in young children are very serious, including impaired cognitive development and poor educational achievement at later ages [3] [4] [5] . Compared with the decreases in deficiencies of vitamin A, iodine, and protein-energy, no significant progress has been made in the control of iron-deficiency anemia among children in developing countries [6] .
A population-based household survey in the mid1990s in São Paulo, Brazil, one of the most economically developed urban centers of Latin America, demonstrated that endemic child anemia was not restricted to poor settings. It found that more than 49% of children aged 6 to 59 months, and nearly 68% of children aged 6 to 23 months, were anemic. Data collected by the same survey suggest that a diet with insufficient available iron (only 23.3% of children received the recommended daily intake of 10 mg of iron) plus a pattern of physical growth (and therefore, normal iron requirements) which resembled the National Center for Health Statistics (NCHS) standards were the main factors contributing to the high risk of child anemia. Fewer than 11% of the children had intestinal parasites, which were mostly Giardia and Ascaris; no child had hookworms [7] .
Fortification of food with iron and the distribution of pharmaceutical iron supplements through the health-care system are the two interventions with greatest potential impact to control iron-deficiency anemia in young children [8] . However, in developing countries, iron-fortified infant foods are usually too expensive to be affordable by the majority of the population, while the distribution of iron supplements in health centers has low coverage and it is usually restricted to pregnant women [8] . Recent well-controlled efficacy studies in iron-depleted Asian preschool children showed that supervised iron supplementation with intermittent dosing schedules (once or twice a week) caused an improvement iron status similar to that caused by daily supplementation [9] [10] [11] . This gave a new impetus to the control of child anemia by distribution of an iron supplement. The purpose of the present study was to evaluate whether, in a child population where anemia was highly prevalent and dietary iron was clearly insufficient, an intervention based on the long-term preventive mass prescription of weekly doses of a cheap solution of iron sulfate to children 6 to 59 months of age would be effective in improving hemoglobin concentrations and reducing the prevalence of infant and child anemia, even when the intake was not supervised.
Subjects and methods

Population studied and evaluation design
The study was part of a large, multipurpose, crosssectional household survey undertaken in the city of São Paulo, Brazil [7] . From September 1995 to September 1996, a random sample of city households (n = 4,560) was visited. Those located in low-, intermediate-, and high-income districts were randomly distributed throughout the survey. Informed consent was obtained from the parents of all participating children, and the study was approved by the Ethics Committee of the School of Public Health of the University of São Paulo.
The hemoglobin concentrations of children from 6 to 59 months of age living in the sampled households (n = 1,158) were measured by a portable photometer. All children examined during household visits between September 1995 and March 1996 (n = 635) were chosen to be control subjects. Parents were told the hemoglobin values of their children, and they were encouraged to increase sources of iron in the children's diet, particularly meat, beans, and dark-green leaves, regardless of the presence or absence of anemia. In the case of anemic control children, the parents were advised to seek treatment for anemia at the nearest public health center. These instructions were limited to three to five minutes.
Children examined from April to September 1996 (n = 499) were chosen to receive the iron supplement. Their parents were also informed of their hemoglobin concentrations and received the same feeding advice given to the control group. Additionally, the parents of the children exposed to the intervention received a syrup containing iron sulfate with instructions to give it to their children once a week until a follow-up visit occurred in about six months. The parents of the children in the intervention group also received a calendar to mark the days on which the children were given the syrup. After a period of six to seven months, both the control and the intervention subjects were revisited for a new hemoglobin test. No contact between the families and the research team occurred in the interval between the two visits.
During the second visit to the household, the calendars left with families in the intervention group were taken by the interviewers. In the absence of marked calendars (42.5% of the cases), the interviewers asked the parents about the frequency of administration of the syrup using a structured questionnaire. Parents of the intervention children were also asked about the intake of iron preparations other than the one provided by the study, and parents of the control subjects were asked about the intake of any iron preparation since the initial visit.
Because of address changes, measurement of the hemoglobin concentration during the second visit was not possible in 76 (12.0%) of the 635 control children and 75 (15.0%) of the 499 intervention children. Almost half of the controls (46.7%, or 261 of 559 children) received iron supplements during the follow-up. Most of these children, as anticipated, were anemic children whose parents had followed the research team's advice to take them for medical treatment. Fifty-five of the 424 intervention children (11.0%), equally divided between the anemic and nonanemic groups, received iron supplements other than the one provided by the study. These two groups (261 + 55) were excluded from the impact study. Children whose duration of follow-up was less than 5 months or equal to or greater than 9 months were also excluded (5 control children and 23 intervention children). After these exclusions, the average duration of the follow-up was 6.9 ± 0.7 months for the control group and 7.0 ± 0.8 months for the intervention group. Therefore, the effectiveness of the preventive weekly iron supplementation described in this study was evaluated on the basis of 293 controls and 346 recipients of the intervention.
The dropouts and, particularly, the children excluded from the impact study may have disturbed the expected randomization of the final control and intervention groups for initial hemoglobin concentration and, possibly, for other relevant baseline variables. This possibility is examined and dealt with in the statistical analysis of this study.
Iron preparation
The syrup of iron sulfate provided to children from the intervention group was prepared by the Department of Nutrition at the School of Public Health of the University of São Paulo. It was bottled in brown glass ampoules of 85 ml, which contained 20 mg/ml of elemental iron. The total amount of elemental iron in each bottle was calculated to be much lower than the lethal dose in case a child accidentally swallowed the whole contents [12] . Each bottle was packed with a small, transparent plastic spoon that had marks indicating different volumes of the solution. The recommended weekly intake of the syrup varied according to the child's age at the start of the intervention to provide 30 mg of elemental iron for children 6 to 9 months old, 40 mg for children 10 to 17 months old, 50 mg for children 18 to 29 months old, 60 mg for children 30 to 35 months old, and 80 mg for children 36 to 59 months old. The recommended intake corresponded to approximately 4 mg of elemental iron per kilogram of body weight. Parents of younger children (up to 29 months) received one bottle, and parents of older children received two bottles.
Data collection
The same data collection procedures were used for children in the control and the intervention groups. Before the enrollment of each child in the study, the parents were interviewed to determine the demographic and socioeconomic conditions of the household, including the child's birth date, the total number of residents, and all sources of family income. A capillary blood sample was obtained at the start and at the end of the study by finger skin puncture by health personnel using a manual skin-puncture device (Beckson Dickson, Rutherford, NJ, USA). Hemoglobin concentration was determined at the household, immediately after the puncture, by the cyanomethemoglobin method using a portable photometer (HemoCue, Angelholm, Sweden) [13] . Weight and height measurements were also taken to provide indicators of the general nutritional status of the children. Weight was measured to the nearest 0.1 kg with an electronic scale (Model 7307, Sohenle, Germany) while the child was minimally clothed. Length was recorded to the nearest 0.1 cm using a special length-measuring board for infants (Ahrtag, London), with the child lying down. For children at least two years of age, stature was recorded to the nearest 0.1 cm using a microtoise (SECA bodymeter 208).
Stool samples were collected at the start to be screened for intestinal parasites at the university parasitology laboratory [14] . The parents were told the results of the stool examination during the second visit to the households, and children with positive findings (mostly Giardia duodenalis and Ascaris lumbricoides; there were no cases of hookworm) received the appropriate drug treatment from the research team. The average daily intakes of energy, protein, vitamin A, and iron were estimated at the start of the follow-up in a systematic subsample of children in both the control and the intervention groups by using 24-hour dietary recalls [15] . Food intake was transformed into nutrients by using the software Virtual Nutri [16] , and the percentages of recommended dietary allowances were calculated according to international recommendations [17, 18] .
Statistical analysis
Several tests and analyses were employed to assess the impact of the intervention outcomes [19] . The independent t-test and the two-sample test for proportions were used to compare the control and intervention groups at the start for the baseline distribution of variables that could influence changes in hemoglobin concentration during the study (initial hemoglobin concentration; age; family income; intestinal parasites; weight-for-age, height-for-age, and weight-for-height indicators; and daily intake and percentage of recommended dietary allowances of energy, protein, vitamin A, and iron). The independent t-test was used to compare the two groups for the variation (increment or decrement) in hemoglobin concentration from the beginning to the end of the follow-up. Linear regression analysis was used to model the change in hemoglobin concentration due to the intervention (this is given by the regression coefficient of a dummy variable that indicates the control or intervention status of each child in a linear model, with the hemoglobin variation during follow-up as the dependent variable). Logistic regression analysis was performed to model relative risks (odds ratios) of increasing or decreasing hemoglobin concentrations and the probability of anemia at the end of the follow-up. Linear and logistic analyses provided crude estimates, and the estimates were adjusted according to baseline variables. Confounders considered were baseline variables whose distribution was different among control and intervention children (p < .20) and the total duration of the follow-up. The age group at the start of the follow-up (6-17 or 18-59 months) and the attained level of compliance, determined either from marked calendars or from parents' reports (75% or more of the planned doses or lower compliance), were investigated as possible modifiers of the impact of the intervention. All statistical analyses were done using STATA [20] . EpiInfo version 6 [21] was used to enter the data and to generate anthropometric indicators based on the National Center for Health Statistics/World Health Organization (NCHS/WHO) standards [22] . Table 1 presents relevant baseline characteristics of children from the final control and the intervention , since anemia prevalence was inversely related to both age and income. Taking into consideration all subjects originally included in the two groups, children in the final control group had a slightly higher prevalence of anemia and lower mean hemoglobin concentration, age, and family income (data not shown).
Results
Other child characteristics that could influence changes in hemoglobin concentration, such as anthropometric indicators, intestinal parasites, and daily intake of energy, protein, iron, and vitamin A, showed a similar baseline distribution in the two groups. It is interesting to note that the means of the anthropometric indicators coincided with the Z scores of the NCHS standards in both groups of children, which indicates that the general nutritional status of the studied population was satisfactory. The same impression comes from the subsample data relative to the daily intake of energy, protein, and retinol, but not of iron, a nutrient clearly deficient in the population (table 1) . In both groups, few children were breastfed, but nearly all consumed cow's milk (average intake of almost 500 ml/day in the two groups). Table 2 describes changes in the children's hemoglobin concentration from the beginning to the end of the follow-up period. The increase is twice as high in the intervention group as in the control group (10.0 vs 4.5 g/L); this makes the mean gain in hemoglobin of the intervention group vis-à-vis the control group equal to 5.5 g/L. This gain, or the mean gain due to the intervention, is reduced to 4.0 g/L when it is modeled through a multiple linear regression which controls the comparison between the two groups for initial hemoglobin concentration, initial age (6-11, 12-17, 18-23, 24-35, 36-47, and 48-59 months of age), logarithm of per capita family income (assessed during the first visit to the households), and total duration of follow-up. Both the crude and the adjusted hemoglobin net gain associated with the intervention were statistically highly significant (p < .01). All control variables included in the linear model were also highly significant (data not shown). Table 3 shows the distribution of the study children according to possible modifiers of the impact of the intervention: the child's age at the start of the follow-up and the level of compliance with the intervention. A high level of compliance (evidence of an effective intake of at least three-quarters of the planned doses of the supplement during the follow-up) was found for 62% of all children offered the intervention (54% for 6-to 17-month-old children and 64% for 18-to 59-month-old children). Table 4 provides estimates of the adjusted mean gain in hemoglobin concentration due to the intervention. These estimates are stratified according to age and level of compliance. As in table 2, they were modeled through a multiple linear regression which takes into account differences between control and intervention children in initial hemoglobin concentration, initial age, logarithm of family income, and duration of follow-up. With the control of these variables, the net gain in hemoglobin concentration due to the intervention was much higher for the high-compliance children than for the low-compliance children (5.0 vs 2.3 g/L), particularly for the younger children (6.6 vs 1.2 g/L). But a positive impact of the intervention was seen for all age and compliance strata, and the net gains were statistically significant for all strata except the younger low-compliance children. Table 5 shows the results of the comparison between control and intervention children for the follow-up incidence of hemoglobin catch-up (defined as changes in hemoglobin concentration greater than +10.0 g/L) and hemoglobin decreases (defined as changes in hemoglobin concentration lower than -10.0 g/L). Adjusted odds ratios provided by logistic regression--which also control for differences between the two groups in initial hemoglobin concentration, initial age, income, and duration of follow-up-indicate that the children who received the intervention tend to be more prone to catch-up concentrations and less prone to decreasing concentrations. Again, the benefits associated with the intervention tend to be directly related to the degree of compliance. In general, the intervention seems to work better in preventing decreases in hemoglobin concentrations (odds ratios for decreases far below 1.0) than in promoting increases in hemoglobin (odds ratios for catch-ups around or not far above 1.0). This preventive effect of the intervention is particularly notable among children from 6 to 17 months old, the age group in which the risk of anemia is higher and the consequences are most serious. Among these children, the intervention reduced by nearly 5 times the chance of a decrease in odds ratios (odds ratio, 0.18; 95% confidence interval, 0.05 to 0.63); the reduction was nearly 15 times when a high compliance was attained (odds ratio, 0.07; 95% confidence interval, 0.01 to 0.63). Table 6 shows predictions of the prevalence of child anemia at the end of the study in the control and intervention groups. These predictions are obtained by modeling the individual probability of a child's being anemic as a function of his or her intervention status (control or beneficiary), as well as a function of initial hemoglobin concentration, initial age, logarithm of family income, and duration of follow-up. The resulting model was run with the follow-up duration set to seven months and the initial hemoglobin concentration, initial age distribution, and family income all set to the average values observed in the cross-sectional random sample of the total population of children in the city of São a. Odds ratios were adjusted for initial age, initial hemoglobin concentration, log of per capita family income, and duration of follow-up. Children with low compliance received less than 75%, and those with high compliance received at least 75%, of the recommended doses of the supplement.
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Paulo. The prevalences in the table may, therefore, be understood as proxies for the magnitude of child anemia in the city of São Paulo if the iron supplementation had or had not been implemented in the entire city. A relative reduction in the prevalence of anemia of more than 50% could be predicted for the young child population of the entire city (from 21.6% to 9.1%). A still stronger impact (from 21.6% to 6.4%, or a relative reduction of 70%) would occur if the overall compliance were that of the high-compliance group. The older children seem to respond better to the intervention, probably because more severe anemia (hemoglobin concentration far below 110 g/L) is more frequent at younger ages. The relative reduction in the prevalence of anemia was 60% (from 13.6% to 5.0%) in the older children and 33% (from 58.2% to 38.5%) in the younger children. If maximization of compliance could be achieved, the prevalence of anemia could be reduced to 70% among older children and 24.5% among younger children (a relative reduction of 57%).
Discussion
Because of ethical constraints, the parents of anemic children receiving the intervention were told their children's hemoglobin concentration and were advised to seek medical treatment at the nearest public health center. This ethically mandatory procedure is not always observed in trials with anemic children. Almost half of these children received some iron supplementation during the follow-up and were excluded from the final analysis for this reason. The hemoglobin changes in this group (not shown in this article) were intermediate between those reported in the control and the intervention groups. The relevant differences between the two groups were appropriately dealt with by adjusting all comparisons between intervention and control children for initial hemoglobin concentration, age, and family income.
We also adjusted all comparisons between control and intervention children for duration of observation. The net average improvement in hemoglobin concentration attributed to the intervention was estimated as 4.0 g/L; the intervention was particularly effective in the important first two years of life. It was notable that among children from 6 to 17 months of age, the risk of a decrease in hemoglobin concentration greater than 10 g/L was five times less in the children exposed to the intervention than in control subjects. Extended to the total population of children in the city of São Paulo, the results would predict a reduction in the prevalence of child anemia of more than 50%. In the intervention group, the parents of almost two-thirds of the children gave their children the iron supplement during at least 75% of the weeks during the follow-up period. As would be expected, the impact of the intervention on this group of children was higher, but both the high-compliance and the low-compliance groups benefited significantly from the intervention.
As mentioned in the introduction, three trials undertaken in iron-depleted Asian preschool populations had already demonstrated that supervised intermittent iron supplementation was as efficacious as supervised daily supplementation [9] [10] [11] . A meta-analysis of the available evidence for the efficacy of intermittent, as compared with daily, iron supplementation (21 trials) estimated that individuals in different age and physiological groups (children, adolescents, and pregnant women) given weekly iron supplementation had an end prevalence of anemia 1.34 times higher (95% confidence interval, 1.20 to 1.49) than those given supervised daily supplementation [23] .
The meta-analysis included four trials with preschool children: two of the three previously cited preschool trials [10, 11] and two still unpublished a. The duration of follow-up was set to 7.0 months, and the initial hemoglobin concentration, initial age, and logarithm of family income in each group were set to the average values found in the random sample of the child population of São Paulo city. b. Children with low compliance received less than 75%, and those with high compliance received at least 75%, of the recommended doses of the supplement.
trials, also undertaken in preschool Asian populations. In these four trials, the end prevalence of anemia was almost the same in the daily and weekly ironsupplementation groups [23] . Only one of the efficacy trials of preschool children reviewed in the metaanalysis had an appropriate control group (children receiving no iron), allowing for the estimation of the absolute efficacy of the weekly iron-supplementation schedule (weekly versus control instead of weekly versus daily). In that trial [11] , the prevalence of anemia decreased by 90% in both the daily and the weekly supplemented groups, whereas it increased by one-third in control subjects.
As stated by the authors of the meta-analysis, efficacy (the capacity to produce the desired effects under experimental conditions) is a necessary but insufficient prerequisite to determining the effectiveness of an intervention (the capacity to produce the desired effects under the conditions of expected usage). Since all reviewed preschool trials were undertaken in very controlled settings, the authors of the meta-analysis state that their results do "…not ensure that either method of administration (daily or weekly) will be effective in controlling iron deficiency and anaemia in operational programmes" [23] .
The trial undertaken in São Paulo was not designed to address the efficacy of weekly iron supplementation, but rather to explore its effectiveness in reducing child anemia, because of the following features: the intake of the supplement was not supervised but, instead, parents were advised to give the supplement to their children; children whose parents reported poor compliance were not excluded from the impact evaluation; and both the children exposed to the intervention and the control subjects were taken from a random sample representative of the total child population of the city. The fact that the advice to give a weekly dose of the iron supplement was offered in the context of field research, and not by the regular personnel from a service institution, could be considered an argument against generalizing the observed impact. However, it is important to consider that the research team had only a single contact with the families at the start of the study. Moreover, no more than five minutes were spent to explain to the parents the need to protect their children from anemia and the importance of giving them the iron supplement regularly.
The fact that in the São Paulo trial a still relatively high end prevalence of anemia was predicted for children entering the intervention at 6 to 17 months of age (37.6%, compared with a prevalence of only 5.4% for older children) deserves additional comment. We see two likely reasons for this high "residual" prevalence of anemia. The first reason refers to the lower compliance rate achieved by the intervention among younger children: 54% of the younger children received at least three-quarters of the planned doses of the supplement, as compared with 64% of the older children. However, this is surely only a partial explanation, since the end prevalence of anemia was still high (24.5%), even when only younger children with high compliance were considered. The second, and probably most important, reason is that the group of younger children started the intervention not only more affected by anemia (with an initial prevalence of 68.2%, compared with 35.2% in older children) but also with a higher proportion of children with very low hemoglobin levels. One-third of the anemic children 6 to 17 months old had hemoglobin concentrations below 9.0 g/L, as compared with one-sixth of the older children. Therefore, the magnitude of the catch-up needed to "cure" anemia in younger children was obviously much higher than that in older children.
It is also important to observe that in the study population the initial prevalence of more severe anemia (hemoglobin concentrations below 9 g/L) increased very fast up to 18 months of age and then decreased: 6.1% in the first 6 months of life, 19.7% from 6 to 12 months, 23.8% from 12 to 18 months, 17.8% from 18 to 24 months, 10.0% from 24 to 36 months, 3.4% from 36 to 48 months, and 2.7% from 48 to 60 months. This may be an indication that to achieve an "acceptable" end prevalence of anemia at the younger ages it would be essential to initiate the weekly supplementation of iron not at 6 months but even earlier.
It is our conclusion that this trial indicates that long-term preventive weekly iron supplementation of preschool children can significantly reduce the risk of anemia under conditions not far from what would be achieved through routine public health programs. This conclusion is strengthened by a previous nineweek trial undertaken in a West Javanese village, not included in the meta-analysis mentioned above. It demonstrated that iron supplements administered weekly by mothers "under real life community conditions" reduced the prevalence of anemia among twoto five-year-old children by half [24] .
The large-scale implementation of a household-level intervention, similar to the one evaluated in São Paulo city but operated by regular health agents and offered to every child when he or she reaches six months of age, has begun in 512 municipalities from the northeast region of Brazil (with an 80% baseline prevalence of anemia around one year of age). It will soon bring new evidence to assess the impact on endemic child anemia that can be expected from programs based on the mass free distribution of iron sulfate weekly [25] .
